✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Newly developed direct-acting anti-viral drugs act as a major breakthrough in the area of HCV therapeutics.
📊
Temel Bulgular & Veri:Accumulating evidence suggest that more than 99% patients achieve sustained virological response after receiving sofosbuvir-based therapy.
💡
Sonuç & Katkı:However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Newly developed direct-acting anti-viral drugs act as a major breakthrough in the area of HCV therapeutics. Accumulating evidence suggest that more than 99% patients achieve sustained virological response after receiving sofosbuvir-based therapy. However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H. Pylori.
🔖
Bu Makaleye Atıf Yap
WAHID, B. (2019). Treatment response of sofosbuvir in HCV virus/ Helicobacter pylori co-infected patient a case report. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 4, 189–191. https://ajindex.com/articles/161840